English
Русский
Eco-vector
Pharmateca
ISSN 2073-4034 (Print) ISSN 2414-9128 (Online)
Menu     Archives
  • Home
  • About the Journal
    • Editorial Team
    • Editorial Policies
    • Author Guidelines
    • About the Journal
  • Issues
    • Search
    • Current
    • Retracted articles
    • Archives
  • Contact
  • Subscriptions
  • All Journals
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
×
User
Forgot password? Register
Notifications
  • View
  • Subscribe
Subscription Login to verify subscription
Search
Browse
  • By Issue
  • By Author
  • By Title
  • Other Journals
  • Categories
Keywords COVID-19 Helicobacter pylori arterial hypertension atopic dermatitis breast cancer bronchial asthma chemotherapy children chronic obstructive pulmonary disease diabetes mellitus insulin resistance metabolic syndrome non-steroidal anti-inflammatory drugs obesity osteoporosis pregnancy probiotics stroke treatment type 2 diabetes mellitus vitamin D
Home > Search > Author Details

Author Details

Sherman, V D

Issue Section Title File
Vol 16, No 6 (2009) Articles Clinical significance of dornase alfa (Pulmozyme) in complex therapy of early age children suffering cystic fybrosis
Vol 18, No 11 (2011) Articles DORNASE ALPHA (PULMOZYME) FOR THE COMPLEX TREATMENT OF BRONCHOPULMONARY PROCESS IN CYSTIC FIBROSIS PATIENTS.
 

 

Developed by ECO-VECTOR

 

Powered by EVESYST

TOP